Mark & Associates, P.C. | Attorneys at Law

Live chat by Boldchat

By submitting this form I agree to the following disclaimer.

TOLL-FREE
1-866-50-RIGHTS
(1-866-507-4448

NEW YORK
626 RexCorp Plaza
Uniondale, NY 11556
p: (516) 333-1415
f: (516) 333-1838

BOSTON
60 State Street,
Suite 700
Boston, MA 02109
p: (617) 742-7700
f: (617) 371-2950

Fighting for Your Legal Rights in Asbestos Exposure Cases

Ninth & Tenth Cases of PML in Tysabri Patients Reported

On June 19, 2009, Biogen Idec Inc. said a ninth Tysabri patient developed a potentially deadly brain infection since the drug was reintroduced to the market in 2006. The drug, which treats multiple sclerosis, was pulled from the market in 2005 following occurrences of a rare, but deadly, brain infection ...